Fluvoxamine + Haloperidol Decanoate Interaction
Moderateinteraction on record
Description
Combined CYP3A4 and CYP2D6 inhibitor that increases haloperidol plasma concentrations; monitor for increased adverse effects including QTc prolongation.
Mechanism
CYP3A4 and CYP2D6 inhibition increases haloperidol concentrations
Source: NLP:haloperidol decanoate